Brief: Unicycive Announces Third Quarter Financial Results

Unicycive Therapeutics

14/11/2022 13:20

Nov 14 (Reuters) - Unicycive Therapeutics Inc  UNCY.O :
    * UNICYCIVE ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * ON TRACK TO FILE NEW DRUG APPLICATION FOR RENAZORB IN 2023
    * QTRLY LOSS PER SHARE $0.37
    * AS OF SEPTEMBER 30, 2022, CASH AND CASH EQUIVALENTS
TOTALED $7.0
MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXc9l6td 
Further company coverage:  UNCY.O 
 ((Reuters.Briefs@thomsonreuters.com;))